Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
04 2021
Historique:
received: 01 07 2020
revised: 22 09 2020
accepted: 20 10 2020
pubmed: 24 11 2020
medline: 4 9 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Early intensive care unit (ICU) admission, in Critically Ill Cancer Patients (CICP), is believed to have contributed to the prognostic improvement of critically ill cancer patients. The primary objective of this study was to assess the association between early ICU admission and hospital mortality in CICP. Retrospective analysis of a prospective multicenter dataset. Early admission was defined as admission in the ICU < 24 h of hospital admission. We assessed the association between early ICU admission and hospital mortality in CICP via survival analysis and propensity score matching. Of the 1011patients in our cohort, 1005 had data available regarding ICU admission timing and were included. Overall, early ICU admission occurred in 455 patients (45.3%). Crude hospital mortality in patients with early and delayed ICU admission was 33.6% (n = 153) vs. 43.1% (n = 237), respectively (P = 0.02). After adjustment for confounders, early compared to late ICU admission was not associated with hospital mortality (HR 0.92; 95%CI 0.76-1.11). After propensity score matching, hospital mortality did not differ between patients with early (35.2%) and late (40.6%) ICU admission (P = 0.13). In the matched cohort, early ICU admission was not associated with mortality after adjustment on SOFA score (HR 0.89; 95%CI 0.71-1.12). Similar results were obtained after adjustment for center effect. In this cohort, early ICU admission was not associated with a better outcome after adjustment for confounder and center effect. The uncertainty with regard to the beneficial effect of early ICU on hospital mortality suggests the need for an interventional study.

Identifiants

pubmed: 33227593
pii: S0883-9441(20)30743-7
doi: 10.1016/j.jcrc.2020.10.022
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-11

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Yannick Hourmant (Y)

Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France.

Achille Kouatchet (A)

Intensive Care Unit, Centre hospitalier régional universitaire, Angers, France.

René López (R)

Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France.

Djamel Mokart (D)

Intensive Care Unit, Institut Paoli Calmettes, Marseille, France.

Frédéric Pène (F)

Medical ICU, Cochin University Hospital, AP-HP, Paris, France.

Julien Mayaux (J)

Medical ICU and Pneumology, Pitié-Salpétrière University Hospital, APHP, Paris, France.

Fabrice Bruneel (F)

Intensive Care Unit, Hôpital André Mignot, Versailles, France.

Christine Lebert (C)

Intensive Care Unit, Centre hospitalier départemental Vendee, La Roche Sur Yon, France.

Anne Renault (A)

Medical ICU, La Cavale Blanche University Hospital, Brest, France.

Anne-Pascale Meert (AP)

Intensive Care Unit, Institut Jules Bordet, Université libre de Bruxelles (ULB), Brussels, Belgium.

Dominique Benoit (D)

Service soins intensifs et urgences oncologiques, Institut Jules Bordet, Brussels, Belgium.

Virginie Lemiale (V)

Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France.

Elie Azoulay (E)

Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France; Faculté de Médecine, Université de Paris, Paris, France; ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (Center of Epidemiology and Biostatistics Sorbonne Paris Cité, CRESS), INSERM, Paris, France.

Michael Darmon (M)

Medical ICU, Saint-Louis University Hospital, AP-HP, Paris, France; Faculté de Médecine, Université de Paris, Paris, France; ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153 (Center of Epidemiology and Biostatistics Sorbonne Paris Cité, CRESS), INSERM, Paris, France. Electronic address: michael.darmon@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH